×

Brain inflammation may help repair myelin, animal study shows

Brain inflammation is often viewed as harmful in neurological diseases such as multiple sclerosis (MS), but a new animal study suggests that certain short-lived forms of inflammation may be needed to help the brain repair myelin. This finding may have important implications for understanding the…

Spinal Cord Lesions are probably overlooked

Tweet Someone has made a comment about the poor impact of treatments on progression and I made comment about trials and you only find lesions if you look for them. MRI can spot lesions if they are big enough but with MRI they seldom look…

Descobreixen com l’esclerosi múltiple pot provocar la mort de neurones, i això és important perquè obre una nova via per a investigar la malaltia

Un equip internacional de recerca ha identificat un mecanisme clau que explica per què, en l’esclerosi múltiple (EM), no només es danya la mielina sinó que també moren neurones del cervell. La troballa aporta una nova perspectiva sobre la malaltia i obre la porta a…

La reparació de la mielina podria estar en un gen d’animals d’alta muntanya

Un equip de científics ha identificat un mecanisme biològic inesperat que podria ajudar a reparar la mielina, la capa protectora dels nervis que es veu danyada en l’esclerosi múltiple (EM). La descoberta prové de l’estudi d’animals d’alta muntanya com els iacs, que han desenvolupat adaptacions…

Antibodies in CNS inhibited by natalizumab, What does this tell us about antibodies?

Tweet It says to me the antibodies in the CNS are inpart generated by the peripheral immune system entering the CNS as natalizumab blocks cells entering the inflammed CNS Background: Cerebrospinal fluid (CSF) kappa free light chains (KFLC) is a sensitive marker of intrathecal immunoglobulin synthesis…

Singing for Wellness

By Stacie Prada Last year, my naturopath suggested I take deep breaths each day, and I agreed it would be good for me. I approached it like a prescription and made sure to do it. I followed guided meditations, and … Continue reading → Source:…

EU experts back tolebrutinib approval for SPMS patients with no relapses

Regulators in the European Union are recommendeding that tolebrutinib be approved as a treatment for people with secondary progressive multiple sclerosis (SPMS) who have not experienced a relapse in the last two years. That new positive opinion was issued by the European Medicines Agency’s Committee…

AAN2026. Barrier to treatment for Ocrelizumab

Tweet MS treatments are expensive and it is OK if you live in a place with Social Medicine but in many parts of the World one of the features that limits access to treatments is economics. It is scandalous that some countries penalise people for…